Pfizer (Pfizer)

Lobbying Organisation Pfizer

Date published 19 Jan, 2018

Relevant Matter Public policy or programme

Public Policy Area Economic Development and Industry

Period 1 Sep, 2017 to 31 Dec, 2017

Specific Details Global competition for foreign direct investment continues to intensify and Ireland continues to compete for such investment. Pfizer has extensive operations in Ireland where many of Pfizer's leading and newest medicines are manufactured for global supply and distribution to over 140 countries worlwide.

Intended results Highlight the importance of Ireland's committment to pro-enterprise policies including the corporation tax rate and medicine access and pricing policies.

Name of person primarily responsible for lobbying on this activity Karen O'Keeffe

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Email (2-5)

emails seeking meetings

Letter (2-5)

Letters to An Taoiseach and the Minister for Finance

Phone call (2-5)

phone calls confirming logistical details

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Leo Varadkar Taoiseach (Department of the Taoiseach)

Paschal Donohoe Minister (Department of Finance)

Micheal Martin TD (Dáil Éireann, the Oireachtas)

Frances Fitzgerald Tánaiste and Minister (Department of Business, Enterprise and Innovation)